Abstract:MicroRNAs, including miR-21, MiR-26a and miR-221/2, are potential key regulators of gene expression in glioblastoma, the most common and the most aggressive type of primary human brain tumor. Their activity is modulated by post-transcriptional factors that regulate mRNA processing pathways and by the abundance of their targets. Despite recent efforts to identify microRNA modulators, this mode of regulation is still poorly understood, and the repertoire and extent that microRNA modulators regulate gene expression in tumors and affect tumorigenesis remain unknown. We developed a genome-wide approach to identify glioblastoma-specific microRNA modulators. We identified hundreds of candidate modulators, including modulators that either activate or suppress miRISC-mediated regulation, and mRNAs that act as decoys and compete for microRNA binding in glioblastoma. Validation experiments were done in SNB19 cell line by measuring differential expression of mature microRNAs and their targets after ectopic expression or inhibition of predicted regulator proteins. 3′ UTR luciferase assays were used to establish the post-transcriptional nature of the regulation. Focusing on two known drivers of gliomagenesis and progression, we showed that PTEN is post-transcriptionally up regulated by WNT7A through miR-21 and down regulated by PALB2 through miR-106a, and that RUNX1 is post-transcriptionally down regulated by WIPF2 through miR-17–5p. Further, we showed that PTEN and RUNX1, which are widely considered functionally unrelated, act as decoys for one another by competing for a common microRNA-regulatory program: they post-transcriptionally regulate one another through their microRNA regulators. In addition, other modulators with prognosis-predictive genetic alterations act through common microRNA-regulatory programs to regulate PTEN and RUNX1 expression. For example, prognosis-predictive genetic alterations at the CTBP2 locus significantly alter both CTBP2 and PTEN expression in glioblastoma; siRNA-mediated silencing of CTBP2 resulted in a 30% reduction in the expression of PTEN 3′ UTR luciferase reporters. Our results demonstrate that microRNA modulators regulate the expression of key glioblastoma drivers, and that genetic alterations at microRNA modulators lead to aberrant post-transcriptional regulation of these drivers. Taken together, these results suggest that microRNA modulation plays a significant role in tumorigenesis and progression of gliobalstoma. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-339. doi:10.1158/1538-7445.AM2011-LB-339

Modulation Of Untranslated Region Alternative Polyadenylation In Glioma Tumorigenesis

The Non-N-6-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma

Alternative Polyadenylation in Glioblastoma Multiforme and Changes in Predicted RNA Binding Protein Profiles.

Alternative Polyadenylation of Mrna and Its Role in Cancer

Alternative Polyadenylation: Methods, Mechanism, Function, and Role in Cancer.

The Regulation of Protein Translation and Its Implications for Cancer

Relationship between NUDT21 mediated alternative polyadenylation process and tumor

Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma

m6A modification in RNA: biogenesis, functions and roles in gliomas

mRNA alternative polyadenylation (APA) in regulation of gene expression and diseases

Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets

The role of RNA modification in the generation of acquired drug resistance in glioma

Insights into the regulatory role of RNA methylation modifications in glioma

Microrna Modulators Regulate Oncogenes And Tumor Suppressors In Glioblastoma

RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma

Alternative polyadenylation shapes the molecular and clinical features of lung adenocarcinoma

Genome-wide Profiling of Polyadenylation Sites Reveals a Link Between Selective Polyadenylation and Cancer Metastasis

The Emerging Roles Of Rna Modifications In Glioblastoma

Gene Expression-Based Predication of RNA Pseudouridine Modification in Tumor Microenvironment and Prognosis of Glioma Patients

Identification and Verification of an Alternative Polyadenylation-Related lncRNA Prognostic Signature for Glioma

Interplay Between PCBP2 and Mirna Modulates ARHGDIA Expression and Function in Glioma Migration and Invasion